<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02957188</url>
  </required_header>
  <id_info>
    <org_study_id>13C EPA and 13C AA metabolism</org_study_id>
    <nct_id>NCT02957188</nct_id>
  </id_info>
  <brief_title>Metabolism of Omega-3 and Omega-6 During Healthy Aging</brief_title>
  <official_title>Metabolism of Uniformly Labelled 13C Eicosapentaenoic Acid and 13C Arachidonic Acid During Healthy Aging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Healthy Aging Research Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the kinetics of 13C-eicosapentaenoic acid (EPA) and
      13C-arachidonic acid (AA) in young and older participants
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Kinetics of 13C-EPA and 13C-AA</measure>
    <time_frame>Plasma incorporation of 13C-EPA or 13C-AA was measured from the area under the curve in young and older participants over 28 days post-dose</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">13</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>Young</arm_group_label>
    <description>Six young (18-30 yrs old) healthy participants were recruited. The study had three blocks of one month: 13C-EPA follow-up, wash-out and 13C-AA follow-up. Each participant orally consumed a single oral dose of 35 mg of 13C-EPA, and after the wash-out, a 50 mg dose of 13C-AA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Elderly</arm_group_label>
    <description>Six older (≥ 70 yrs old) healthy participants were recruited. The study had three blocks of one month: 13C-EPA follow-up, wash-out and 13C-AA follow-up. Each participant orally consumed a single oral dose of 35 mg of 13C-EPA, and after the wash-out, a 50 mg dose of 13C-AA.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>13C eicosapentaenoic acid and 13C arachidonic acid</intervention_name>
    <description>Each participant orally consumed a single oral dose of 35 mg of 13C-EPA, and after the wash-out, a 50 mg dose of 13C-AA.</description>
    <arm_group_label>Young</arm_group_label>
    <arm_group_label>Elderly</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Fasted blood samples were collected before breakfast (baseline) and thereafter at 2 h, 4 h, 6
      h, 24 h, 7 d, 14 d, after the tracer intake.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Young and elderly healthy participants
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  six young (18-30 y old) and six older (≥ 70 y old)

          -  healthy non medicated participants.

        Exclusion Criteria:

          -  Tobacco,

          -  malnutrition (assessed from blood albumin, haemoglobin and lipids), -

          -  participants taking an EPA+DHA supplements or consuming more than 2 fish meals per
             week,

          -  severe gastro-intestinal problems,

          -  medication for diabetes,

          -  thyroid disease,

          -  renal failure,

          -  cancer,

          -  psychiatric difficulties or depression,

          -  cardiovascular disease,

          -  glucose intolerance (&gt;8 mmol/L in fasted samples)

          -  chronic immune condition or inflammation (CRP &gt; 10 mg/l, white cell count),

          -  recent major surgery or cardiac event,

          -  dementia,

          -  ongoing or past severe drug or alcohol abuse,

          -  ongoing or past intensive physical training.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2016</study_first_submitted>
  <study_first_submitted_qc>November 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2016</study_first_posted>
  <last_update_submitted>November 2, 2016</last_update_submitted>
  <last_update_submitted_qc>November 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université de Sherbrooke</investigator_affiliation>
    <investigator_full_name>Mélanie Plourde</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Eicosapentaenoic acid</keyword>
  <keyword>Arachidonic acid</keyword>
  <keyword>Metabolism</keyword>
  <keyword>Healthy aging</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

